Exhibit 99.1


For Immediate Release:

WYETH APPEALS 10-YEAR OLD MATERNA LITIGATION TO SUPREME COURT

Fairfield, CT (February 12, 2004): Competitive Technologies, Inc.
(AMEX: CTT) announced that it has been advised that Wyeth (NYSE:
WYE) has filed an appeal to the Supreme Court of the United
States on the $58.2 million patent infringement judgment for
fraud and unjust enrichment against Wyeth, and in favor of CTT's
client, the University of Colorado.

On November 12, 2003, the US Court of Appeals for the Federal
Circuit denied a rehearing/rehearing en banc for this case of the
Court's September 3, 2003 affirmation of the August 13, 2002
decision of US Senior District Court Judge John Kane of the US
District Court for the District of Colorado.  A preliminary
opinion issued in July 2000 found that Drs. Robert H. Allen and
Paul A. Seligman at the University of Colorado, a CTT client, are
the sole inventors of the improved formulation of the prenatal
vitamin supplement, and that Wyeth had committed fraud and was
unjustly enriched.

John B. Nano, President and CEO of CTT said, "We fully anticipate
that the highest court in the nation will not hear a case already
decided by multiple decisions of the lower courts and will
continue to find in favor of the University et al to finally
close this litigation which began in 1993 for product sales
between 1984 and 1994.  Wyeth seems to be unfairly determined to
delay the resolution of the case after more than ten years."

Mr. Nano continued, "We had expected that in proper use of the
judicial process and a sense of fairness to the University, the
citizens of Colorado, and the doctors, that Wyeth would not
continue to appeal these judgements against their position.  SEC
filings indicate that Wyeth accrued a litigation reserve of
nearly $17 billion over the last several years.  According to
court filings they are involved in over 25,000 court cases."

The litigation involves a prenatal vitamin supplement marketed by
Wyeth under the Materna(TM) name.  The US District Court for the
District of Colorado and the US Court of Appeals for the Federal
Circuit found that Wyeth had committed fraud for unjust
enrichment.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the
technology needs of its customers and transforming those
requirements into commercially viable solutions.  CTT is a global
leader in identifying, developing and commercializing innovative
technologies in life, digital, nano, and physical sciences
developed by universities, companies and inventors.  The global
market for technology transfer services is estimated at $150
billion annually.  CTT maximizes the value of intellectual assets
for the benefit of its customers, clients and shareholders.
Visit CTT's website: http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in
this document other than historical facts are "forward-looking
statements" within the meaning of applicable Federal Securities
Laws and are not guarantees of future performance.  These
statements involve risks and uncertainties, including those set
forth in Item 1 of the Company's most recent Form 10-K and in
CTT's other filings with the SEC, and are subject to change at
any time.  The Company's actual results could differ materially
from these forward-looking statements.  The Company undertakes no
obligation to update publicly any forward-looking statement.

Direct inquiries to:     Johnnie D. Johnson, Strategic IR,Inc.
                         E-mail:   jdjohnson@strategic-ir.com
                         Tel.      (212) 754-6565;
                         Fax       (212) 754-4333
                         E-mail:   ctt@competitivetech.net